STRUCTURED ABSTRACT
OBJECTIVES To compare surgical outcomes of patients with endometrial cancer who underwent robotic surgery across different BMI categories.
METHODS A retrospective study including all consecutive patients with endometrial cancer who underwent robotic surgery at a tertiary cancer center between December 2007 and December 2022. The study analyzed outcome measures, including blood loss, surgical times, length of hospitalization, perioperative complications, and conversion rates with the Kruskal-Wallis test for BMI group differences and the Chi-squared test for associations between categorical variables.
RESULTS A total of 1,329 patients with endometrial cancer were included in the study. Patients were stratified by BMI: <30.0 (n=576; 43.3%), 30.0-39.9 (n=449; 33.8%), and ≥40.0 (n=304; 22.9%). There were no significant differences in post-anesthesia care unit (PACU) stay (p=0.105) and hospital stay (p=0.497) between the groups. The rate of post-op complications was similar across the groups, ranging from 8.0% to 9.5% (p=0.761). The rate of conversion to laparotomy was also similar across the groups, ranging from 0.7% to 1.0% (p=0.885). Women with a BMI ≥40.0 had a non-clinically relevant but greater median estimated blood loss (30 mL vs. 20 mL; p<0.001) and longer median operating room (OR) time (288 minutes vs. 270 minutes; p<0.001). Within the OR time, the median set-up time was longer for those with a higher BMI (58 minutes vs. 50 minutes; p<0.001). However, skin-to-skin time (209 minutes vs. 203 minutes; p=0.202) and post-op time (14 minutes vs. 13 minutes; p=0.094) were comparable between groups.
CONCLUSION BMI does not affect the peri-operative outcome of patients undergoing robotic staging procedures for endometrial cancer.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Research Ethics Committee of the Jewish General Hospital gave ethical approval for this work (2019-1292, 03-041).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability Statement
All data produced in the present study are available upon reasonable request to the authors.
Approvals
The study was approved by the Research Ethics Board of the Jewish General Hospital (2019-1292, 03-041).
ABBREVIATIONS
- ANOVA
- Analysis of Variance
- ASA
- American Society of Anesthesiologists
- BMI
- Body Mass Index
- EBL
- Estimated Blood Loss
- EIN
- Endometrial Intraepithelial Neoplasia
- ER
- Emergency Room
- IQR
- Interquartile Range
- OR
- Operating Room
- PACU
- Post-Anesthesia Care Unit
- SD
- Standard Deviation
